Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Contineum Therapeutics has raised $99.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Contineum Therapeutics's investors include Perceptive Advisors, Samsara BioCapital, Versant Ventures, Casdin Capital, Hadean Ventures.
Contineum Therapeutics is headquartered in San Diego, United States.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Contineum Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Contineum Therapeutics — Funding & Investors." VCBacked, December 11, 2025, https://www.vcbacked.co/company/contineum-therapeutics. Accessed November 13, 2026.
VCBacked. (2025). Contineum Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/contineum-therapeutics
{{cite web |title=Contineum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/contineum-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Contineum Therapeutics? Request a listing update